Shared by
beno
Fundamentals
Shares Outstanding: 32.8m (latest)
Cash: 2.55m (+ $8m from Jan 28 offering, + $17.5m from Feb 19 offering)
Current liabilities: 537k
Current ratio: 6.72
NWC (total current assets - total current liabilities): 3.07m
Monthly Burn rate (net loss / months): 578k
Estimated current cash: 527k
Accumulated deficit: 38m
Book value (Stock holder equity / Shares outstanding): 0.223 (no longer accurate with new SO)
Catalysts / News / Painting the picture
-Receives FDA Fast track for its Oncorpex Immunogene therapy that targets lung cancer
-Sign Exclusive License Agreement with University of Pittsburgh for Potentially Curative Gene Therapy Candidate for Diabetes
-$25m shelf, recent offering 17/01/20 for $1.267m
-2020-01-28: Closes $8m offering
-2020-02-21: Closes $17.5m offering
-Enough cash for 43.5 months! Doesn't need to do another offering for awhile!
-2020-03-05: Lead Researcher Behind Genprexs Diabetes Gene Therapy Featured in New Video Interview
Technical Analysis
-Intraday pattern: Runner
-Levels: 1.60, 2.20, 2.50, 3, 3.80 (death line from 2 weeks ago)
Original Plan / Strategy
FT-15 short of 3.80 death line from 2 weeks ago
Review
This was an extremely good setup that I failed to get big in.
Execution detail:
| Date/time | Symbol | Side | Price | Position |
|---|---|---|---|---|
| 2020-03-17 15:15:03 | GNPX | sell | $3.590 | short |
| 2020-03-17 15:18:10 | GNPX | buy | $3.370 | 0 |
| 2020-03-17 15:21:07 | GNPX | sell | $3.600 | short |
| 2020-03-17 15:21:09 | GNPX | sell | $3.650 | short |
| 2020-03-17 15:21:21 | GNPX | sell | $3.790 | short |
| 2020-03-17 15:22:38 | GNPX | buy | $3.590 | 0 |
Leave a comment about this trade!
You need to log into your Tradervue account to leave a comment. If you don't have one,
it takes
just a few seconds to sign up, and it's free!